TD Cowen analyst Tara Bancroft reiterated a Buy on Sutro Biopharma (NASDAQ: STRO).The analyst commented, "Enrollment completed in Part One ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE